The global preterm birth diagnostic test kit market is slated to reach a value of USD 152.2 million in 2024 and expand at a CAGR of 7.6% to reach USD 316.5 million by 2034.
The sector accounted for around 1% of the global rapid diagnostic test kit industry in 2021. The absence of cognizance about preterm diagnostic kits in the developing economies of Asia Pacific, Middle East, and Africa exhibits several lucrative opportunities for the vendors.
The high costs associated with hospital admissions place a financial burden on people depending on out-of-pocket expenditures for preterm diagnostic solutions.
The preterm diagnostic test kits are easily available and provide swift results for the detection of preterm labor and damage to membranes. The escalating demand for economical diagnostic tests surges the sales of preterm birth screening kits between 2024 and 2034.
Preterm Birth Awareness Plans to Go Global
Several local and international firms have launched schemes to cater to the advancing preterm birth scenario. Such campaigns aim aiding amplify awareness about preterm births, their detection, and their symptoms.
March of Dimes, a United States non-profit organization, rallied a “Prematurity Campaign Collaborative” comprising 200 prominent maternal and child health firms along with parents and community associations.
The campaign aimed at facilitating foster communities where premature newborns are given the care required to lead a healthy life. The ascending consciousness concerning preterm births assists in creating sufficient diagnostic technologies strengthening the demand for preterm birth diagnostic test kits.
Growth Factors of Preterm Birth Diagnostic Test Kit Market in North America
North America induces considerable growth from 2024 to 2034 because of the economics of preterm birth screening kits and ongoing technical innovations, which are the main catalysts of the preterm birth diagnostic test kit industry growth.
North America's prominent healthcare costs on medical care management and thriving disposable income augment the demand for preterm birth diagnostic testing equipment in North America.
The presence of recognized industry competitors and the favorable legislative framework prompted product approvals and introductions, and as a result, the preterm birth diagnostic test kit market expansion strengthened during the forecast period.
| Attributes | Description |
|---|---|
| Estimated Global Preterm Birth Diagnostic Test Kit Market Size (2024E) | USD 152.2 million |
| Projected Global Preterm Birth Diagnostic Test Kit Market Value (2034F) | USD 316.5 million |
| Value-based CAGR (2024 to 2034) | 7.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Growth Determinants in the Preterm Birth Screening Kit Industry
Childbirth before 37 weeks of pregnancy, termed preterm birth, is a noteworthy health issue globally. The greater frequency of preterm births amplifies the demand for precise and steady preterm birth diagnostic screening kits to recognize and speculate preterm labor.
This catalyst has the potential to continue as medical care providers and governments emphasize curbing preterm birth rates and enhancing maternal and newborn health results. This factor strengthens the global growth of the preterm birth diagnostic test kit market.
Progress in medical technology has led to the innovations of experienced and precise diagnostic test kits for envisioning preterm birth. The preterm birth diagnostic test kits adopt techniques like genetic testing, biomarker analysis, and ultrasound estimations. As this equipment develops and is widely accessible, it aids the growth of the preterm birth diagnostic test kit industry.
Deterrents Impeding the Preterm Birth Diagnostic Testing Equipment Sector
The medical diagnostic sector is administered to assure patient security and product efficiency. Making and introducing new diagnostic test kits to the industry needs intense testing and approval procedures. Regulatory obstacles hinder the launch of new test kits to the sector, adversely influencing the adoption of preterm birth diagnostic test kits.
Few advanced diagnostic test kits are expensive to research, manufacture, and buy. The cost stimulus constrains availability, especially in economies with fewer healthcare resources or where medical care is not well-resourced to dispense modern diagnostic services. Towering costs inhibit healthcare amenities from embracing new technologies, impeding preterm birth diagnostic test kit market growth.
Between 2019 and 2023, the preterm birth diagnostic test kit market saw steady growth because of booming awareness regarding preterm birth intricacies and diagnostic technology innovations.
The preterm birth diagnostic testing kit sector evolved at a CAGR of 7.2% from 2019 to 2023, catapulted by the soaring prevalence of preterm births and schemes by healthcare institutions to constrain neonatal casualty rates. Partnerships between healthcare organizations and diagnostic kit producers amplified the preterm birth diagnostic testing equipment market expansion.
From 2024 to 2034, the preterm birth diagnostic test kit demand is likely to strengthen significantly. This escalation is characterized by numerous factors, like an aging population, rising maternal age, lifestyle shifts resulting in higher occurrences of preterm births, and the launch of modern diagnostic solutions.
The government schemes targeted at enhancing maternal and child healthcare in developing economies flourish the growth of the preterm birth diagnostic test kit sector.
The evolution in precision medicine and tailored healthcare soars the adoption of progressive diagnostic techniques, intensifying the preterm birth diagnostic test equipment adoption. The preterm birth diagnostic test kit manufacturers stress product innovation and partnerships to take advantage of emerging prospects and cater to shifting customer requirements.
Principal Consultant
The section below covers the forecast for the preterm birth diagnostic test equipment market in terms of countries. Information on key countries in several parts of the globe, including North America, Asia Pacific, Europe, and others, is provided.
The United States remains at the forefront in North America, with a CAGR of 8.1% through 2034. In the Asia Pacific region, China is projected to witness a CAGR of 10.3% by 2034, leaving behind India at 8.6%.
| Countries | CAGR (From 2024 to 2034) |
|---|---|
| United States | 8.1% |
| Germany | 7.3% |
| France | 7.5% |
| China | 10.3% |
| India | 8.6% |
Technological innovations and strong research escalated the advancement and adoption of preterm birth diagnostic tests in the United States. The United States exhibits modern healthcare infrastructure, prospectively intensifying the demand for preterm birth diagnostic test kits.
The occurrence of risk factors like obesity and maternal age highlights the requirement for productive preterm birth screening techniques in the United States
With a focus on prenatal care, there is a responsive sector for dependable preterm birth diagnostic kits in the United States. Strong government schemes and medical care policies stimulate the sales of preterm birth diagnostic testing equipment in the United States.
The recognized healthcare system in Germany stimulates the broad adoption of preterm birth diagnostic kits. With a focus on preventive healthcare, the rising interest in early screening kits for preterm birth in German healthcare providers is a documentation of their commitment and significance in transforming the healthcare future.
Considerable attention to child and maternal health initiatives presents opportunities for combining preterm birth diagnostic solutions into the traditional healthcare ecosystem in Germany. The aging population and falling birth rates in Germany accentuate the necessity of precise preterm birth tests in maternal health care.
The comprehensive healthcare coverage in France facilitates the adoption of preterm birth diagnostic test kits. A culturally ingrained focus on maternal and child health intensifies the demand for preterm birth screening kits in France. French government schemes to minimize preterm birth rates encourage investments in diagnostic technologies customized to the healthcare ecosystem.
The presence of medical research and innovation in France prompts the innovation of modern preterm birth diagnostic solutions. The surging consciousness among pregnant women and medical care providers about the concerns of preterm birth strengthens the demand for diagnostic alternatives in France.
The section contains information about the leading sectors in the preterm birth diagnostic testing equipment industry. In terms of product category, the PAMG-1 Test segment is estimated to account for a share of 62.6% by 2034. By sample type category, the blood segment is projected to dominate by holding a share of 42.2% in 2034.
| Segment | PAMG-1 Test |
|---|---|
| Value Share (2034) | 62.6% |
The PAMG-1 Test is efficient in identifying preterm labor risks and provides timely intervention, curbing the chances of complications. Healthcare providers look out for PAMG-1 because of its proven dependability and ease of application in medical settings. PAMG-1 has a proven track record that highlights its role in augmenting maternal and neonatal results.
The choice for PAMG-1 emerges because of its proficiency in serving the essential demand for preterm birth projection, boosting its sales. The ascendancy of PAMG-1 indicates the recognition of its key role in strengthening preterm birth management techniques.
| Segment | Blood |
|---|---|
| Value Share (2034) | 42.2% |
The recognized infrastructure for blood sample collection and diagnosis assists the demand for blood-based diagnostic kits. Healthcare providers value the exhaustive insights presented by blood tests, sustaining knowledgeable decision-making and customized patient care.
The ongoing innovations in blood-based diagnostic technologies improve the efficiency of preterm birth diagnostic test kits, and escalate the market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market characterizes a myriad landscape with preterm birth diagnostic testing equipment vendors contending for a significant share. The leading manufacturers use technological innovations and medical research to present groundbreaking solutions.
The reputed preterm birth diagnostic test kit producers, along with rising startups, said the market dynamics, escalating competition through differentiation, strategies, and regional expansion.
Regulatory authorizations and collaborations with healthcare centers are critical for market entry. The continuous research and partnerships target improving diagnostic precision and expanding market access. The competitive landscape exhibits a blend of recognized preterm birth diagnostic testing kit vendors and startups vying to cater to persistent healthcare requirements linked to preterm birth.
Industry Updates
| Company | Sera Prognostics |
|---|---|
| Headquarter | United States |
| Recent Advancement |
|
| Company | Nuvo Group |
|---|---|
| Headquarter | Israel |
| Recent Advancement | Nuvo Group got the United States FDA approval for the expanded application of its INVU, a prescription-based remote pregnancy monitoring system to add a uterine activity module that allows remote screening of uterine activity. |
The report consists of key products like ffN test, PAMG-1 test, and IGFBP-1 test.
The market is trifurcated into blood, urine, and vaginal discharge.
Key end users present in the industry include hospitals, diagnostic laboratories, outpatient clinics, and research centers.
Analysis of the market has been carried out in key countries of North America, Latin America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe, and the Middle East and Africa.
The demand revenue to acquire USD 152.2 million in 2024.
The preterm birth diagnostic testing equipment industry to be worth USD 316.5 million by 2034.
The sales analysis infers a CAGR of 7.6% through 2034.
From 2019 to 2023, the industry evolved at a 7.2% CAGR.
The PAMG-1 test sector to capture a share of 62.6% in 2024.
The blood segment to clutch a share of 42.2% in 2024
1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
5. Pricing Analysis
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
6.1. Product
6.2. Sample
6.3. End User
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
7.1. FFN Test
7.2. PAMG-1 Test
7.3. IGFBP-1 Test
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Sample
8.1. Blood
8.2. Urine
8.3. Vaginal Discharge
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
9.1. Hospitals
9.2. Diagnostic Laboratories
9.3. Outpatient Clinics
9.4. Research Centres
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
10.1. North America
10.2. Latin America
10.3. Western Europe
10.4. South Asia
10.5. East Asia
10.6. Eastern Europe
10.7. Middle East & Africa
11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
14. South Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
16. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
17. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
18. Sales Forecast 2024 to 2034 by Product, Sample, and End User for 30 Countries
19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
20. Company Profile
20.1. Qiagen
20.2. Medix Biochemica
20.3. Hologic Inc.
20.4. Sera Prognostics
20.5. IQ Products
20.6. Creative Diagnostics
20.7. Nanjing Liming Biological Preparations Co., Ltd.
20.8. Clinical Innovations, LLC
20.9. Bioserv Diagnostic GmbH
Explore Healthcare Insights
View Reports
Preterm Birth Diagnostic Test Kit Market
